Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|6|539-546

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.6, 2016-06, pp. : 539-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-04 ,pp. : 672-693

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Identification and Development of InhA Direct Inhibitors of Mycobacterium tuberculosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-03 ,pp. : 182-193

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Modern InhA Inhibitors to Combat Drug Resistant Strains of Mycobacterium tuberculosis

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 489-498

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Discovery of BACE Inhibitors

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-01 ,pp. : 3383-3404

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the drug discovery of non-peptidic BACE1 inhibitors

By Hamada Yoshio   Kiso Yoshiaki  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 391-416

Informa Healthcare

Access to resources Recommend Favorite